The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Fund Price: $48.11 (as at September 20, 2017)  1-day chg: $.12006 0.25%  YTD: 21.57%

Returns as at August 31, 2017

  Fund Group Avg Index*
1 Month 1.67% 1.13% 0.67%
3 Months 6.06% -2.73% -0.15%
6 Months 10.33% 5.21% 0.28%
1 Year 15.32% 11.77% 7.23%
2 Year Avg 7.24% 9.29% 7.96%
3 Year Avg 11.16% 12.82% 2.10%
4 Year Avg 17.23% 16.03% 7.85%
5 Year Avg 19.88% 17.40% 8.13%
10 Year Avg - 9.05% 4.10%
15 Year Avg - 9.05% 8.54%
20 Year Avg - 7.25% 6.74%
Since Inception 17.84% - -
 
2016 -4.84% 0.11% 21.08%
2015 7.10% 17.95% -8.32%
2014 33.63% 19.62% 10.55%
 
3 year risk 13.91 14.30 7.65
3 year beta 0.69 0.50 1.00

*S&P/TSX Total Return

Growth of $10,000

This graph shows how a $10,000 investment in this fund would have changed in value compared with the S&P/TSX Total Return.

Risk Measures as at August 31, 2017

Best/Worst 12 months (since inception)
Best (ending Feb 14): 46.71 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Worst (ending Feb 16): -8.52 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Volatility meter (Based on 3 year standard deviation from GlobeInvestor.com)
Low VOLATILITY METER: 14 High

Fund Objectives

The BMO Equal Weight US Health Care Hedged to CAD Index ETF has been designed to replicate, to the extent possible, the performance of the Solactive Equal Weight US Health Care Index Canadian Dollar Hedged, net of expenses. The Fund invests in and holds the Constituent Securities of the Index in the same proportion as they are reflected in the Index. The US dollar exposure is hedged back to Canadian dollars.

Fund Facts

Fund Sponsor: BMO Asset Management Inc.
Managed by: Jones Heward Investment Counsel
Fund Type: MF Trust
Inception Date: May 2010
Asset Class: Sector Equity
Quartile Rank: 3 (3YR ending August 31, 2017)
Total Assets: N/A
Mgmt Exp. Ratio (MER): 0.39%
Management Fee: 0.35%
Load Type: No Load
Globe 5-Star Rating:
RRSP Eligible:
Canadian
Min. Invest (initial):
-
Subsequent:
-
Min. Invest (initial RRSP):
-
Subsequent RRSP:
-
Closed:
No
Restricted:
No
Restriction:
 
 

Asset Allocation August 31, 2017

Equity Sector Weightings August 31, 2017

Fund Geography August 31, 2017

Top Holdings as at August 31, 2017

Symbol Company Name Sector Geographic
Area
Asset
Type
% of
Total Assets
  Performance as at September 20, 2017
1 Year Performance (%)
VRTX-Q Vertex Pharmaceuticals Biotechnology & Pharmaceuticals United States Stock 3.05   65.61 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
ISRG-Q Intuitive Surgical Inc. Biotechnology & Pharmaceuticals United States Stock 2.44   46.53 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
CNC-N Centene Corporation Medical Services United States Stock 2.32   32.89 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
BCR-N Bard C R Inc. Biotechnology & Pharmaceuticals United States Stock 2.3   38.89 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
REGN-Q Regeneron Pharmaceuticals Biotechnology & Pharmaceuticals United States Stock 2.29   6.62 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
A-N Agilent Technologies Inc. Electrical & Electronic United States Stock 2.22   43.18 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
EW-N Edwards Lifesciences Biotechnology & Pharmaceuticals United States Stock 2.19   -7.42 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
GILD-Q Gilead Sciences Biotechnology & Pharmaceuticals United States Stock 2.19   1.13 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
ILMN-Q Illumina Inc. Biotechnology & Pharmaceuticals United States Stock 2.18   12.21 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
CI-N Cigna Corp. Insurance United States Stock 2.14   37.39 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)

Distribution Report (18 months up to September 20, 2017)

Frequency of Income Distributions: Quarterly

Frequency of Capital Gain Distributions: Annually

Date Income Dividend Capital Gain Total (Current Period) Trailing 12-Months Total Reinvestment Price
Dec 23, 2016 0.1900 0.1900 0.1900 40.011

Portfolio Manager(s)

Team Managed

Jones Heward Investment Counsel

Start Date: May, 2010

Fund Return: 17.85%

Also manages:BMO Aggregate Bond Index ETF, BMO Dow Jones Industrial Avg CA ETF, BMO EW US Banks Hgd CAD Index ETF, BMO Emer Mkts Bd Hdg to CAD Idx ETF, BMO Equal Weight REITs Index ETF, BMO Equal Weight Utilities ETF, BMO Global Infrastructure Index ETF, BMO High Yield US Corp Bond Hed ETF, BMO India Equity Index ETF, BMO Junior Gas Index ETF, BMO Junior Oil Index ETF, BMO Mid Corporate Bond Index ETF, BMO Mid Federal Bond Index ETF, BMO Real Return Bond Index ETF, BMO S&P/TSX Capped Comp Index ETF, BMO S&P/TSX EW Gbl Base Metals ETF, BMO S&P/TSX EW Oil & Gas Index ETF

View fund manager performance report